Portuguese 
English 
Spanish 
4 min of reading 
0 comments 
With an Investment of R$ 100 Million, Vitamedic Starts the Operation of Its New Factory in Anápolis, Expanding Supplement Production and Strengthening Its Verticalization Strategy.
Vitamedic started in October the pre-operational phase of its new factory in Anápolis (GO), a decisive step in its expansion plan.
The unit, built after an investment of R$ 100 million, was designed to expand the production of supplements and vitamins, ensure greater quality control, and respond to the growing demand in the sector.
The company expects that full operation will be achieved progressively, with total capacity anticipated between 2026 and 2027.
-
Historic bankruptcy of Centauro shocks the market, and the century-old company puts more than 500,000 products, machines, and complete infrastructure up for online auction.
-
New shoe factory in Ceará is expected to create 400 jobs and strengthen the local economy.
-
No one imagined it, but a mixture of sawdust with a mineral that fights fires surprises scientists with a result that changes the course of fire-resistant construction.
-
From empty land to a high-end house, wooden construction uses a lightweight system, metal structure for the foundation, ventilated ceramic cladding, and special windows to create an efficient and comfortable living space throughout the year.
Robust Investment from Vitamedic
The significant investment made by Vitamedic has a clearly defined destination. Of the total, R$ 70 million was specifically directed to the new factory, including infrastructure, machinery, and utilities.
Only for construction and equipment, R$ 35 million was invested. Another R$ 25 million will be used for the launch and internalization of around 200 SKUs by 2026.
And R$ 10 million was reserved for marketing and trade actions, reinforcing the brand’s presence on the shelves.
The remaining R$ 30 million was previously used at the effervescent plant, inaugurated in 2023, complementing Vitamedic’s verticalization strategy.
Modern Facilities and Pharmaceutical Standards as Differentiators
The new factory, built alongside Vitamedic’s pharmaceutical complex, follows a production model that adopts quality parameters typical of the pharmaceutical industry.
This standard includes stability control, complete traceability, and automatic processes that reduce variations between batches—essential elements to ensure safety and performance.
This structure reinforces the company’s positioning as one of the most stringent when it comes to quality in supplements.
Why Did Vitamedic Decide to Verticalize Its Production?
The decision to expand and produce supplements internally is the result of years of market study.
According to the management of Grupo José Alves, Vitamedic observed the evolution of consumption, tested categories, validated retail service, and consolidated recognition among the public.
With this maturity, the company concluded that controlling the entire chain—from raw materials to final products—is the way to gain competitiveness, speed up launches, and ensure a uniform quality standard.
Expectation is that this strategy will increase the operational margin by 15 to 20 percentage points, directly reflecting on EBITDA.
Production Capacity and Formats of the New Factory
The new factory was designed to operate continuously, 24 hours a day, seven days a week.
When it reaches full performance, the unit will have the capacity to produce 1.5 million units per month.
The industrial park includes various technologies, allowing the manufacture of sugar-free gummies, soluble powders, capsules, sachets, edible gels, and sticks.
Products such as beverages and bars will remain outsourced until the sales volume justifies future internalization.
International Certifications and Standardization Advance in the Timeline
Vitamedic is also working to expand its global presence. The new factory is already undergoing the FDA certification process, the regulatory body of the United States.
Furthermore, the products must adhere to anti-doping protocols, ensuring that no ingredients banned by sports committees are present in the formulations.
When fully integrated into operations, the unit is expected to represent about one-third of the company’s annual revenue.
Market Growth Drives Vitamedic’s Strategy
The expansion takes place at a time when the supplement market is steadily growing in Brazil.
The search for preventive health and well-being has driven categories such as vitamins, minerals, and functional products.
In this scenario, companies capable of offering quality, scale, and speed of development stand out in retail.
Vitamedic, with the new factory and an investment of R$ 100 million, aims to establish itself among the national leaders in the segment.
For consumers, the new factory means more product options, greater sensory stability, and better standardization.
Verticalization also tends to make the process more agile and predictable, benefiting distribution.
For the sector, Vitamedic’s entry with such a structure elevates the competitive level, encourages innovation, and contributes to the professionalization of the supplement industry in the country.
A New Chapter for Vitamedic
The new factory represents more than physical expansion: it symbolizes a new level for Vitamedic.
With the verticalization of production, strong investment, and a focus on technology and quality, the company positions itself for accelerated growth in the coming years.
The project consolidates the brand in the supplements and vitamins market and reinforces its ability to respond to consumption trends with efficiency, rigor, and innovation.
Seja o primeiro a reagir!